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Summary 
The recently cloned murine fit3 ligand (FL) was studied for its ability to stimulate the growth 
of primitive (Lin-Sca-1 +) and more committed (Lin-Sca-1-) routine bone marrow progenitor 
cells, alone and in combination with other hematopoietic growth factors (HGFs).  Whereas FL 
was a weak proliferative stimulator alone, it potently synergized with a number of other HGFs, 
including all four colony-stimulating factor (CSF), interleukin (IL) 6, I1:11, IL-12, and stem cell 
factor (SCF), to promote the colony formation of Lin- Sca-1 +, but not Lin- Sca-1 -  or erythroid 
progenitor cells. The synergistic activity of FL was concentration dependent, with maximum 
stimulation occurring at 250 ng/ml, and was observed when cells were plated at a concentration 
of one cell per culture, suggesting that its effects are directly mediated. 2 wk of treatment with 
FL in combination with I1:3 or SCF resulted in the production of a high proportion of mature 
myeloid cells (granulocytes and macrophages), whereas the combination of FL with G-CSF, IL-11, 
or I1:12 resulted predominantly in the formation of cells with an immature blast cell appearance. 
Accordingly, FL in combination with G-CSF or I1:11 expanded the number of progenitors more 
than 40-fold after 2 wk incubation. Thus, FL emerges as a potent synergistic HGF, that in com- 
bination with numerous other HGFs, can directly stimulate the proliferation, myeloid differenti- 
ation, and expansion of primitive hematopoietic progenitor ceils. 
H 
ematopoiesis  is  tightly  regulated,  at  least  in  part 
through the complex and opposing actions of soluble 
stimulatory and inhibitory hematopoietic growth factors 
(HGF) 1 (1-3).  An important, if not essential phenomenon 
in early hematopoiesis is synergy among HGFs, in that most 
primitive progenitors can only be recruited to proliferate in 
vitro by the combined stimulation of multiple HGFs (1-3). 
In contrast, committed progenitors can usually be recruited 
by stimulation with a single cytokine, although synergism 
between multiple cytokines might result in enhanced prolifer- 
ation of each progenitor cell (3). A number of HGFs could 
be grouped as synergistic HGFs since they have little or no 
in vitro effect on proliferation alone, and act predominantly 
1 Abbreviations used in this paper: BFU-E, burst-forming unit erythroid; 
CFC, colony-forming cells; Epo, rHu-erythropoietin; FL, fit3 ligand; HGF, 
hematopoietic growth factor; HPP, high proliferative potential; LPP, low 
proliferative potential;  rMu, recombinant  murine;  rr, recombinant  rat. 
to enhance the growth promoting activity of other HGFs, 
such as the CSFs and Epo (1-3).  The synergistic HGFs in- 
dude IL-1, I1:6, IL-11, II.-12, leukemia inhibitory factor (LIF), 
and stem cell factor (SCF). 
The growth-promoting effects of SCF appear to be pre- 
dominantly on primitive progenitors or stem cells, although 
more committed progenitors of the myeloid/erythroid and 
mast cell lineage also respond to SCF (4-8).  Furthermore, 
SCF is a very potent growth stimulator when combined with 
other cytokines, and no other cloned HGF can synergize with 
as many cytokines as SCF (7). Thus, potent synergistic inter- 
actions on the growth of primitive hematopoietic progen- 
itors has been observed between SCF and the CSFs, rHu- 
erythropoietin (Epo), IL-1, 1I:6,  IL-11, and IL-12 (4-14). 
The effects of SCF are signaled through the c-kit tyrosine 
kinase receptor (15, 16) that is closely related to c-fms (17) 
and the flt3/flk-2 receptor (18, 19). Whereas c-fms appears 
to be expressed on both primitive and mature myeloid pro- 
genitors, flt3/flk-2 is thought to be expressed exclusively on 
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ligand (FL) (20-22) has allowed us to investigate the poten- 
tial role of this cytokine in hematopoiesis.  The cloning papers 
demonstrated that FL synergized with II.-3, IL-6, and SCF 
to enhance the growth of primitive murine hematopoietic 
progenitor cells (20, 21), but the potential interaction of FL 
with other HGFs, as well as its effects on differentiation and 
expansion of progenitors, were not examined. We here dem- 
onstrate the direct and potent ability of FL to synergize with 
a number of HGFs to induce the growth of primitive mu- 
fine bone marrow progenitor cells. 
Materials and Methods 
Hematopoietic Growth Factors.  Recombinant murine fit3 ligand 
was cloned  and purified  as previously  described (20). Purified  recom- 
binant murine (rMu)Ib3  was from Peprotech Inc. (Rocky Hill, 
NJ).  Purified rHuG-CSF, rMuGM-CSF  and  recombinant  rat 
(rr)SCF were generously supplied  by Dr. Ian K. McNiece (Amgen 
Biologicals, Thousand Oaks, CA). rHuCSF-1 was kindly provided 
by Dr. Michael Geier (Cetus Corp., Emeryville,  CA), and rHUIL-6 
and rHuIbll was a gift from Genetics  Institute (Cambridge, MA). 
rMuIL-12 was a generous gift from Dr. Stan Wolf (Genetics Insti- 
tute, Cambridge, MA). Epo was purchased from Cilag AG (Schaff- 
hausen, Switzerland), Growth factors were used at predetermined 
optimal concentrations; 20 ng/ml rMuGM-CSF, 50 ng/ml rHuG- 
CSF, 20 ng/ml rMuIL-3, 50 ng/ml rHuCSF-1, 100 ng/ml rrSCF, 
50 ng/ml rHull.,6, 50 ng/ml rHulL-11, 50 ng/ml rMulL-12, 5 IU/ml 
rHuEpo, and 250 ng/ml rMuFL. 
Isolation of Lin-Sca-1 + and Lin-Sca-1 - Bone Marrow Cells.  Lin- 
bone marrow cells were isolated from femurs of normal C57BL/6 
mice (5-8 wk old), according to a previously described protocol 
(14, 23). Briefly, low density bone marrow cells were incubated 
at 4~  for 30 rain in a cocktail of predetermined optimal concen- 
trations of antibodies; RA3-6B2 (13220 antigen; PharMingen, San 
Diego,  CA),  RB6-8C5 (GR-1 antigen;  PharMingen),  MAC-1 
(Serotec Ltd., Oxfordshire, UK), Lyt-2  (CD8; PharMingen), L3T4 
(CD4; PharMingen), and TER-119 (gift from Dr. Tatsuo Kina, 
Kyoto University,  Kyoto,  Japan). Sheep anti-rat IgG (Fc)-conjugated 
immunomagnetic beads (Dynal, Oslo, Norway) were added at a 
cell to bead ratio of 1:20, and incubated at 4~  for 30 rain. Labeled 
(Lin +) cells were removed by a magnetic particle concentrator 
(Dynal), and Lin- cells recovered from the supematant. Lin-Sca-1  + 
cells were isolated as described previously (14, 23, 24). Briefly, 
4-6  x  107 Lin- cells  were resuspended per ml of complete IMDM 
and incubated for 30 rain on ice with either FITC-conjugated rat 
anti-mouse Sca-1 antibody (clone E13161-7; PharMingen) or an 
isotype-matched  control antibody.  The cells were washed twice, and 
Lin-Sca-1- and Lin-Sca-1  + cells sorted on a Epics Elite Cell Sorter 
(Coulter Electronics, Hialeah, FL). The final recovery  of Lin-Sca-1  + 
cells was 0.05-0.1%  of the unfractionated bone marrow. 
Single Cell Proliferation Assay.  Lin-Sca-1  + or Lin -Sca-1 - cells 
were seeded in microtiter plates (Nunc, Kamstrup, Denmark) at 
a concentration of 1 cell per well in a volume of 20 #1 IMDM 
(GIBCO BRL, Paisley, UK) supplemented with 20% FCS (Bio- 
Whittaker,  Inc., Walkersville, MD),  penicillin, and r-glutamine 
(complete IMDM). In some experiments, an Epics Elite Call Sorter 
equipped with a single-call  depositor was used to plate single cells. 
This method assures reproducibly that ~>99% of the wells contain 
one cell. Similar results were obtained with both methods. Wells 
were scored for colony growth (>50 cells) and clusters (10-50 cells) 
after 12-14 d of incubation at 37~  and 5% COs in air. In some 
experiments individual  colonies were sampled, transferred to slides 
by a cytospin  centrifuge,  and examined  morphologically  after Giemsa 
staining. 
Replating Experiments~Colony Formation in  Semisolid Medium. 
After 14 d of incubation of Lin-Sca-1  § bone marrow cells in com- 
plete IMDM supplemented with different growth factor combina- 
tions, cells  were counted, and 500 cells plated in a two-layer  agarose 
culture  as previously described (25). o~-MEM (GIBCO  BRL, 
Gaithersburg, MD) supplemented with 20% FCS was used in the 
colony assays. Cytokines were incorporated into a 1-ml underlayer 
with Sea plaque agarose (FMC BioProducts, Rockland, ME) at 
a final  concentration of  0.5%, whereas cells were incorporated into 
a 0.5-ml overlayer  with a final sea plaque agarose concentration 
of 0.3%. After 12-14 d of incubation at 5% 02, 10% CO2, and 
85%  Ns,  cultures were scored for colony-forming cells (CFC) 
with low or high proliferative  potential (LPP-CFC and HPP-CFC, 
respectively) according to established criteria (25, 26). Erythroid 
colony assays  were performed in complete IMDM and 1.2% (final 
concentration)  methylcellulose (Methocel; Fluka Chemie  AG, 
Buchs, Switzerland). Cultures were scored for burst-forming unit 
erythroid (BFU-E) colonies after 7-8 d of incubation at 37~  in 
5% COs, in air. In some experiments, IMDM with 20% FCS was 
replaced by a serum-free medium (x-vivo 15, BioWhittaker) sup- 
plemented with 1% detoxified bovine serum albumin (Stem Cell 
Technologies Inc., Vancouver, Canada) 
Cell Mo~hology/lmmune  Phenotyping.  Lin-Sca-1  + cells were 
plated in complete  IMDM and incubated for 12-14 d with predeter- 
mined optimal concentrations ofcytokines at 37~  and 5% COs 
in air. Cell morphology was determined after Giemsa staining of 
cytospin  preparations. Cells were examined  for expression of GR-1 
and MAC-1 after 11-12 d of incubation in FL  +  G-CSF or FL 
+  IL-11. Cells were harvested, washed, and incubated for 30 min 
on  ice  with  predetermined  optimal  concentrations  of FITC- 
conjugated anti-GR-1 antibody (PharMingen) and a PE-conjugated 
anti-Mac-1 antibody (PharMingen), or isotype matched irrelevant 
control antibodies (PharMingen). Fluorescence  intensity was ana- 
lyzed by a Coulter Epics Elite FACS. 
Results 
As few as 100 Lin-Sca-1 + cells can radioprotect 50% of 
lethally irradiated mice,  and long-term reconstitute all cell 
lineages in the blood (23, 24; Veiby, O. P., unpublished data). 
FL  (30-1,000  ng/ml)  stimulated  few  or  no  colonies  of 
Lin-Sca-1 + bone marrow cells, and no colonies were formed 
in response  to ILll (50 ng/ml) alone (Fig.  1). However, in 
combination with Ib11, FL stimulated in a concentration- 
dependent manner the colony formation of Lin-Sca-1 + pro- 
genitor cells (Fig. 1). A maximum stimulation (67 colonies) 
was  seen at FL 250  ng/ml, and an EDs0 was observed  at 
~60 ng/ml of FL. A similar EDs0 was observed when Ib12 
(50 ng/ml) was combined with escalating concentrations of 
FL, and maximum colony formation (39 colonies) was again 
seen in response to 250 ng/ml FL (Fig. 1). Since these experi- 
ments were performed on Lin-Sca-1 + cells cultured at one 
cell per well, they suggested that FL in combination with 
IL-11 or IL-12 in a direct manner can potently stimulate the 
growth of primitive hematopoietic progenitor cells. 
Next,  Lin-Sca-1 + progenitors  were  stimulated by 250 
ng/ml of FL and increasing concentrations of II.-11 and Ib 
12. Maximum colony formation was observed at 5 to 50 ng/ml 
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combination with ILl1 and IL-12. Lin-Sca-1  + cells were plated at one 
cell per well in 20 gl complete  IMDM supplemented  with rHuIb11 (50 
ng/ml) or rMuIL-12  (50 rig/m1), and exposed  to increasing  concentrations 
of  rMuFL as indicated.  Wells  were  scored  for colony  formation  after  12-14 d 
of incubation at 37~  in 5% CO2, in air. Results represent the mean 
(SEM) of four separate experiments. * No colonies were formed  in re- 
sponse to IL-11 or IL-12 in the absence of FL. 
of I1,11 and 20 ng/ml of I1,12,  whereas the EDs0 was 0.5 
ng/ml and 0.2-2 ng/ml for I1,11 and I1,12, respectively (data 
not shown). 
Lin-Sca-1 + bone marrow ceils plated at a concentration 
of one cell per well (300 wells per group) were next cultured 
in FL (250 ng/ml) in combination with other cytokines. In 
these experiments we also examined whether the ability of 
FL to enhance colony formation of Lin-Sca-1 + progenitor 
cells was due to recruitment of additional progenitors, and/or 
an increase in the size of responding clones from clusters to 
colonies. These studies demonstrated that the synergistic effects 
of FL in general were due to an increase in the total number 
of proliferating clones, in that both the number of dusters 
and big colonies was enhanced (Table 1).  FL alone stimu- 
lated only the formation of a low number of clusters,  and 
in agreement with previous reports (20, 21), FL synergized 
with I1,3 to increase the doning frequency of Lin-Sca-1 + 
progenitor cells (from 23 to 98 clones). Not previously shown, 
FL also potently enhanced G-CSF-stimulated colony growth. 
Whereas G-CSF alone stimulated the formation of only five 
dusters and one colony, the addition of FL resulted in the 
formation of 14 dusters and 69 colonies (Table 1). Although 
the combination of FL and CSF-1 was not at all as potent as 
FL  +  I1,3 or FL  +  G-CSF, FL enhanced the number of 
CSF-l-responsive clones from 7 to 21. Similarly, GM-CSF- 
induced donogenic progenitors were increased from 6 to 38 
in the presence of FL (Table 1). Interestingly, a synergistic 
enhancement of FL was  also  observed on SCF-stimulated 
colony formation (from 12 to 45 clones). Finally, whereas 
no colonies and only a low number of dusters were observed 
in response to I1,6,  I1,11,  or I1,12  alone, FL increased the 
number of proliferative clones to 62, 72, and 42, respectively. 
Thus, FL directly and synergistically enhances the growth 
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Table 1.  The Effect of FL on Colony Formation of 
Lin- Sca-1 + Progenitor Cells 
Clone size* 
Cytokines  1  2  3  4 
Total 
clones/ 
300 cells 
Medium  0(0)  0(0)  0(0)  0(0)  0(0) 
FL  3(2)  0(0)  0(0)  0(0)  3(2) 
IL-3  8(1)  9(1)  3(2)  3(1)  23(3) 
FL+IL-3  14(4)  41(6)  26(5)  18(2)  98(8) 
G-CSF  5(3)  1(1)  0(0)  0(0)  6(3) 
FL+G-CSF  14(3)  50(5)  16(4)  3(1)  82(7) 
csF-1  3(1)  3(1)  1(1)  0(0)  7(2) 
FL+CSF-1  6(1)  10(2)  3(1)  2(1)  21(2) 
GM-CSF  1(0)  3(1)  2(1)  0(0)  6(2) 
FL+GM-CSF  10(3)  13(5)  8(3)  7(3)  38(10) 
CSF  3(0)  4(1)  5(2)  0(0)  12(3) 
FL+SCF  15(4)  22(5)  8(2)  1(1)  42(9) 
IL-6  2(1)  0((3)  0(0)  0((3)  2(1) 
FL+IL-6  13(2)  40(7)  6(2)  3(1)  62(9) 
Ir-11  2(1)  0(0)  0(0)  0(0)  2(1) 
FL+IL-11  13(2)  36(5)  16(4)  7(2)  72(12) 
Ir-12  0(0)  0(0)  0(0)  0(0)  0(0) 
FL+IL-12  12(3)  23(4)  6(3)  0(0)  42(7) 
Lin-Sca-1  § bone marrow cells were isolated as described in Materials 
and Methods, plated at one cell per well in 20 #1 complete  IMDM, and 
supplemented with predetermined  optimal concentrations of cytokines 
(Materials and Methods). Wells were scored  for cell growth after 12-14-d 
incubation at 37~  and 5% CO2 in humidified air. 
* Scoring criteria: 1, 10-50 cells; 2, 50 cells to 10% of well covered  by 
cells; 3, Cells covering 10-50% of well; 4, >50% of well covered  by 
cells. The results represent the mean (SEM) of five  separate  experiments. 
of primitive murine hematopoietic progenitor cells in com- 
bination with multiple HGFs. 
We have recently demonstrated that I1,12, in combination 
with SCF is a potent synergistic growth factor for Lin-Sca- 
1 + bone marrow progenitor cells (14).  Here, we compared 
the ability of FL and SCF to stimulate colony formation in 
combination with I1,12 (Table 2). Whereas FL (250 ng/ml) 
in combination with II,12 (50 ng/ml) stimulated the forma- 
tion of 37 dusters or colonies, the combined action of SCF 
(100 ng/ml) and II.-12 induced the outgrowth of 55 clones 
(Table 2).  However, the most dramatic difference between 
the FL  +  I1,12 and SCF  +  I1,12 response was with regard 
to the size of the clones formed (Table 2). Specifically, whereas 
FL  +  II,12 stimulated the formation of only four colonies 
covering more than 10% of the well and no colonies covering 
over 50% of the well, SCF and I1,12 in combination resulted 
in formation of 17 colonies covering 10-50%, and 15 colo- 
nies covering more than 50% of the well. Furthermore, the 
trifactor combination of SCF  +  FL  +  I1,12 stimulated 97 Table 2.  Synergistic  Effects  of IL-12 on FL and SCF-stimulated 
Colony Formation  of Lin-Sca-1 + Progenitor  Cells 
Clone size 
Cytokines  1  2  3  4 
Total 
clones/ 
300 cells 
FL  2(1)  0(0)  0(0)  0(0)  2(1) 
SCF  3(1)  4(2)  6(2)  0(0)  13(3) 
FL + SCF  17(4)  20(5)  6(2)  0(0)  43(10) 
FL + IL-12  14(3)  19(4)  4(2)  0(0)  37(5) 
SCF + IL-12  10(2)  14(4)  17(5)  15(4)  55(6) 
FL + SCF + IL-12  9(3)  31(6)  29(7)  28(6)  97(11) 
Lin-Sca-l+ bone marrow cells were plated at one cell per well in the 
presence of predetermined optimal concentrations of cytokines (Materi- 
als and Methods) as indicated, and scored for cell growth after 12-14-d 
incubation at 37~  in 5% CO2 in air. Scoring criteria were as in Ta- 
ble 1. Results represent the mean (SEM) of four separate experiments. 
colonies out of 300 Lin-Sca-1 + cells,  and 28 of these cov- 
ered more than  50%  of the well (Table  2). 
To investigate whether more committed hematopoietic pro- 
genitor  cells  were also responsive to FL,  Lin-Sca-1-  cells 
were cultured in FL (250 ng/ml), in the absence or presence 
of other HGFs. No colonies were formed in response to FL 
alone, or in combination with I1.11 or Ib12 (data not shown). 
In  agreement  with  previous studies  (13),  II.-3 and G-CSF 
stimulated colony formation of Lin-Sca-1-  progenitor cells 
(25  _+  4 and 5  _+  2 colonies, respectively), but FL did not 
synergize with II:3 or G-CSF (28  _  3 and 7  _+  2 colonies, 
respectively). 
In contrast to II.-4 and SCF, FL did not stimulate BFU-E 
colony formation  of Lin-  bone marrow cells  in combina- 
tion with Epo (Fig. 2), suggesting in agreement with previous 
studies (20,  21),  that  FL might  not  stimulate  the growth 
of erythroid progenitor cells. Furthermore, in serum-free cul- 
tures FL did not  enhance  the number  of BFU-E colonies 
formed in response to IL-3  +  Epo or II.-3  +  SCF  +  Epo 
(data not  shown). 
To determine the morphology of the progeny of Lin- Sca- 
1 + cells formed in response to FL, 2,000 Lin-Sca-1 + cells 
were cultured in the presence of FL in combination with other 
cytokines for 2 wk, and cytospin preparations were analyzed 
morphologically.  No viable cells were observed after  14 d 
of incubation with FL alone. However, after 7-10 d of incu- 
bation with FL a population of 100% blast cells was observed, 
whereas SCF-stimulated cultures in comparison contained a 
high proportion of granulocytes (data not shown). Whereas 
I1-3 alone stimulated the formation of 47% granulocytes and 
50% macrophages after 12-14 d of incubation,  FL  +  Ib3 
stimulated the formation of 80% macrophages and only 16% 
granulocytes (Table 3). Only 3% undifferentiated blast cells 
were observed in response to I1-3,  both in the absence and 
presence of FL (Table 3). In contrast, cultures supplemented 
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Figure 2,  Effects  of SCF, Ib4, and FL on erythroid colony formation. 
Lin- cells were isolated, and plated at 2  x  104 cells in semisolid medium 
as described in the Materials and Methods. Cultures were done in tripli- 
cates, and supplemented with predetermined  optimal concentrations  of 
cytokines (Materials and Methods) as indicated. BFU-E colony formation 
was scored after 7-8 d of incubation  at 37~  in 5% CO2, in air. Results 
represent the mean (SEM) of three separate experiments. 
with FL  +  G-CSF contained  65%  undifferentiated blasts, 
6% granulocytes, and 29% macrophages (Table 3). In agree- 
ment with other studies (10, 13, 14), SCF alone stimulated 
the formation of predominantly granulocytes (90%), and a 
low number of macrophages (4%) and blast calls (6%). Simi- 
larly, 73% granulocytes, 9% macrophages, and 18% blasts 
Table 3.  Effects  of FL on the Differentiation  of Lin-Sca-1 § 
Bone Marrow  Cells 
Percent  Percent  Percent 
Cytokines  Cells  granulocytes  macrophages  blasts* 
x  104 
IL-3  8(4)  47(7)  50(8)  3(2) 
FL + IL-3  36(11)  16(5)  80(9)  3(3) 
FL + G-CSF  27(10)  6(2)  29(9)  65(8) 
SCF  2(1)  90(4)  4(2)  6(3) 
FL + SCF  5(1)  73(5)  9(3)  18(7) 
FL + IL-11  26(8)  5(2)  35(8)  60(8) 
FL + IL-12  8(3)  7(3)  17(6)  77(9) 
SCF + IL-12  59(9)  91(5)  4(3)  5(2) 
Two thousand Lin-Sca-l+ cells  were plated in 300/~1 complete IMDM 
supplemented with predetermined  optimal concentrations  of cytokines 
(Materials and Methods) as indicated. Total cell numbers were counted, 
and cytospin preparations were stained with Giemsa after 12-14-d incu- 
bation. Morphology  was examined under a light microscope. At least 
100 cells were examined per group in each experiment.  Results are the 
mean (SEM) of six separate experiments. In the presence of G-CSF, IL-11, 
IL-12, of FL alone no or almost no viable cells were observed (not shown). 
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of the cells harvested from cultures supplemented with FL 
+  I1.11 were granulocytes, whereas 35% were macrophages, 
and 60% blast cells. Similarly, 7% of the cells formed in re- 
sponse to FL +  I1.12 were granulocytes, 17% macrophages, 
and 77%  undifferentiated blast cells  (Table 3).  In compar- 
ison SCF  +  II-12 stimulated almost exclusively the produc- 
tion of granulocytes (91%), and a very low number of blasts 
(5%0). 
To further support the finding that Lin-Sca-1 + progen- 
itors produce myeloid progeny in response to FL, we exam- 
ined the expression of MAC-1 and GP,.-1, two myeloid cell 
surface antigens (27, 28). After 11-12 d of incubation in FL 
+  G-CSF, 25% of the cells expressed GR-1 and 60% MAC-1 
(Table 4). Similarly 28 and 78% of cells formed in response 
to FL  +  I1-11 were positive for GR-1 and MAC-l, respec- 
tively (Table  4). 
300 Lin-Sca-1 * cells were next cultured individually, and 
for each treatment a total of at least 50 colonies covering more 
than 5% of the well were sampled in six experiments to de- 
termine the direct effect of FL on the relative production of 
CFU-G, CFU-M, CFU-GM, and CFU-blast (CFU-B). In 
response to I1-3 a mean of 19 +_ 4 clones were formed. 46  _+ 
12% of the sampled colonies were CFU-G,  11% CFU-M, 
43% CFU-GM, whereas no CFU-B were observed (data not 
shown). In contrast, only 3  _+  2% of the colonies produced 
in response to FL +  I1-3 (87 _. 9 clones total) were CFU-G, 
62  +_  16% were CFU-M, 33  _+  9% CFU-GM,  and 2  _+ 
1% CFU-B. FL  +  G-CSF (76  +_  8 clones) stimulated pre- 
dominantly CFU-GM (46 _+  12%), a high number of CFU-B 
(23  -+  8%), 12  _+  4% CFU-M, and 19  _+  5% CFU-G. FL 
+  I1-11 (75  _+  13 clones) stimulated 2  +_  1% CFU-G, 37 
+  5% CFU-M, 38 +_ 7% CFU-GM, and 23 _+ 6% CFU-B. 
In response to FL +  I1-12 (38 _+ 6 clones) 11 _+  3% of sam- 
pled colonies were CFU-G, 56  _+  8% CFU-GM, and 33  +_ 
8% CFU-B. In comparison, 81  _+  14% of examined colo- 
nies induced by SCF  +  I1.12 (59 _+  8 clones) were CFU-G, 
Table 4.  Expression of MAC-1  and GR-I  on Lin-Sca-1 § 
Progeny Stimulated by FL 
GR-l-positive  MAC-l-positive 
Cytokines  cells  cells 
%  % 
FL + G-CSF  25(7)  60(8) 
FL + IL-11  28(6)  78(11) 
2,000 Lin- Sca-1  + bone marrow cells were incubated in predetermined 
optimal concentrations  of FL + G-CSF or FL + IL-11 for 11-12 d. Cells 
were harvested, and 5 x  104 celXs were incubated with FITC-conjugated 
GR-1- or PE-conjugated  MAC-1 antibodies as described  in the Materi- 
als and Methods. Results  are from  three separate  experiments  and represent 
the mean (SEM) percentage  of GR-1- and MAC-l-positive  cells, as com- 
pared to cells incubated with irrelevant control antibodies. 
2  _+  1% CFU-M,  16  +  4%, and  1  _+  1% CFU-B (data 
not shown). 
When Epo in four experiments was included in the cul- 
tures of Lin-Sca-1 + cells stimulated with FL  +  II.-11 or FL 
+  G-CSF, the number of CFU-G, CFU-M, CFU-GM, and 
CFU-B did not change significantly,  and no BFU-E and only 
a low number of mixed (myeloid plus erythroid) colonies 
(2  _+  1 and  1  _+  1 in response to FL  +  I1.11 and FL  + 
G-CSF, respectively) were observed (data not shown). 
The fact that FL in combination with some HGFs, such 
as II.,11 and G-CSF appeared to increase the production of 
cells with an immature morphology after as much as 2 wk 
of incubation, led us to examine whether FL might in fact 
induce an expansion of the number of progenitors after the 
same period of time. This was done by measuring the number 
of HPP-CFCs, demonstrated to be among the most primi- 
tive hematopoietic progenitors measurable in vitro, as well 
as LPP-CFC, that represents a population of more committed 
progenitor cells  (25,  26).  The input  of 2,000 Lin-Sca-1 + 
cells at the start of the incubation produced 108 HPP-CFC 
and 234 LPP-CFC colonies in response to a cocktail of CSF-1 
+  ILl  +  II-3  +  SCF (Table 5). After 14 d of incubation, 
the FL  +  I1.11-stimulated culture contained  1.48  x  105 
cells, which represented a 74-fold expansion of  the total number 
of cells. These cells contained a total of 5032 HPP-CFC (47- 
fold increase), and 9786 LPP-CFC (42-fold increase). Simi- 
larly, a 98-fold increase in cell number was observed when 
Lin-Sca-1 + cells were stimulated by FL +  G-CSF, and this 
corresponded to a 40-fold and 101-fold increase in HPP-CFC 
and LPP-CFC, respectively (Table 5). Finally,  we examined 
the ability of FL  +  Ib3 to expand the number of progen- 
itors, since this combination appeared much less efficient in 
maintaining a high proportion of immature cells  than FL 
+  Ibll and FL  +  G-CSF (Table 3). Although this combi- 
Table 5.  Amplification of HPP-CFC and LPP-CFC from 
Lin-Sca-1 + Progenitor Cells by FL 
Cytokines  Total cells  HPP-CFC  LPP-CFC 
x  104 
Input  0.2  108 (43)  234 (75) 
FL+ IL-11  14.8 (2.5)  5032 (1367)  9786 (2417) 
FL + G-CSF  19.6 (4.1)  4312 (952)  23520 (4762) 
FL+IL-3  18.5 (3.9)  93 (55)  1480 (370) 
2,000 (input) Liri-Sca-1  + cells were plated in complete  IMDM in the 
presence  of predetermined  optimal concentrations  of cytokines  as indicated. 
After 14 d of incubation the total number of nucleated cells was deter- 
mined for each group, and 500 cells were plated in the double  layer  colo- 
ny assay  (Materials and Methods)  in the presence  of  predetermined  optimal 
concentrations  of CSF-1, IL-1, IL-3, and SCF. Following  another 12-14 d 
of incubation at 37~  in 5% O2 and 10% CO2, in air, cultures were 
scored for HPP-CFC and LPP-CFC  colony  growth. In each experiment 
triplicate cultures were done  for each group. Results represent the mean 
(SEM) of three separate experiments. 
1361  Jacobsen  et at. nation also potently stimulated the total cell production (93- 
fold increase), no amplification of the number of HPP-CFC 
was observed. However, an expansion of LPP-CFC (sixfold) 
was observed (Table  5). 
Discussion 
In agreement with recent studies (20, 21), we found FL 
alone  to be a  weak proliferative  stimulus  for Lin-Sca-1 + 
progenitors, and in fact much weaker than SCF alone. How- 
ever, potent synergistic effects of FL was observed in combi- 
nation with I1:3, GM-CSF, G-CSF, CSF-1, SCF, I1:6, I1:11, 
and I1:12.  The degree of synergy between FL plus I1:3 and 
FL plus SCF was more pronounced in the present study, than 
reported  in  the original  cloning papers  (20,  21).  Since  no 
dose--response of FL was reported in these studies, it is pos- 
sible that the original studies were not performed with op- 
timal concentrations of FL. Alternatively,  the difference might 
be due to the fact that different progenitor cell populations 
were used in  the different studies. 
Interestingly,  the strongest  synergy was observed when 
FL was combined with ligands signaling through members 
of the hematopoietin receptor family (G-CSF, GM-CSF, I1:3, 
I1:6, I1:11, and I1:12), whereas weaker synergy was seen when 
FL was combined with one of the other ligands for tyrosine 
kinase receptors (CSF-1 and SCF). Maximum stimulation of 
the proliferation of Lin-Sca-1 + progenitors required as much 
as 125-250 ng/ml of FL. In comparison,  optimal effects of 
SCF are observed at 100 ng/ml.  Since we have recently ob- 
served a tendency of the murine but not the human FL to 
aggregate (Lyman S. D., unpublished observations), the op- 
timal concentration  of FL might  prove to be lower. 
The present studies demonstrate that I1:12 also potently 
enhances Fbstimulated proliferation of Lin-Sca-1 + progen- 
itors, although less efficiently than in combination with SCF. 
In addition,  the potent trifactor combination of FL  +  SCF 
+  I1:12 stimulated one out of three Lin-Sca-1 + progenitors 
to proliferate, many of them forming very large colonies. Thus, 
the present data further underscores the ability of II.-12 to 
act as a direct synergistic growth factor on primitive hema- 
topoietic progenitor cells. 
In agreement with others (20, 21), we found no effect of 
FL on Epo-stimulated BFU-E colony formation, at variance 
with the potent synergy observed between SCF and EPO. Since 
our studies were performed on restricted progenitor cell popu- 
lations, further studies are required to rule out the involve- 
ment of fit3 signaling  on erythroid and other committed pro- 
genitor cells. The fact that FL supports the formation of mature 
myeloid cells suggest that FL might also support the growth 
of subsets of more mature hematopoietic cells. However, at 
the moment it appears that SCF affects a broader range of 
murine  hematopoietic  progenitors  than  FL. 
The morphological examination of cells formed by Lin-- 
Sca-1 + progenitors after as much as 12-14 d in culture, dem- 
onstrated that  FL in combination with other HGFs could 
potently stimulate the production of cells with an immature 
blast  appearance.  Although  immunophenotyping  demon- 
strated that the majority of the cells formed in response to 
FL +  G-CSF and FL  +  I1:11 expressed myeloid cell surface 
antigens, the replating studies demonstrated by day 14 a more 
than  40-fold increase  in  the number  of HPP-CFCs.  Thus, 
FL can in combination with other cytokines induce myeloid 
differentiation,  but also expand the number of primitive (HPP- 
CFC) and more committed (LPP-CFC) bone marrow pro- 
genitors. Thus, FL might prove efficient in a transplantation 
setting. 
A potential important  role of FL in early hematopoiesis 
was also supported by a recent study where antisense oligo- 
nucleotides against STK-1 (the human  homologue of mu- 
rine fit3),  potently inhibited  colony formation  of CD34 + 
human bone marrow cells, in particular in long-term bone 
marrow cultures (29).  However, since no genetic mutations 
of fit3 or FL affecting hematopoiesis have yet been identified, 
the physiological role of FL in hematopoiesis remains to be 
determined. 
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